Published in Am J Pathol on July 19, 2007
High-mobility group box 1, oxidative stress, and disease. Antioxid Redox Signal (2011) 2.19
HMGB1 in health and disease. Mol Aspects Med (2014) 1.67
Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia (2009) 1.66
A Cdo-Bnip-2-Cdc42 signaling pathway regulates p38alpha/beta MAPK activity and myogenic differentiation. J Cell Biol (2008) 1.39
S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem (2011) 1.22
The receptor RAGE: Bridging inflammation and cancer. Cell Commun Signal (2009) 1.20
S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Cardiovasc Psychiatry Neurol (2010) 0.99
Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas. World J Surg Oncol (2010) 0.94
Receptor for advanced glycation end products (RAGE) partially mediates HMGB1-ERKs activation in clear cell renal cell carcinoma. J Cancer Res Clin Oncol (2011) 0.89
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA. Nat Commun (2013) 0.88
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration. PLoS One (2012) 0.87
Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. Age (Dordr) (2010) 0.87
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer. Cell Death Dis (2014) 0.86
Rhabdomyosarcomas: an overview on the experimental animal models. J Cell Mol Med (2012) 0.84
Stem cell activation in skeletal muscle regeneration. Cell Mol Life Sci (2015) 0.83
Knockdown of HMGB1 improves apoptosis and suppresses proliferation and invasion of glioma cells. Chin J Cancer Res (2014) 0.83
Multiple sites of highly amplified DNA sequences detected by molecular cytogenetic analysis in HS-RMS-2, a new pleomorphic rhabdomyosarcoma cell line. Am J Cancer Res (2012) 0.81
Transcriptional profile of GTP-mediated differentiation of C2C12 skeletal muscle cells. Purinergic Signal (2011) 0.80
Immune-based therapeutics for pediatric cancer. Expert Opin Biol Ther (2010) 0.78
Paradoxical Role of High Mobility Group Box 1 in Glioma: A Suppressor or a Promoter? Oncol Rev (2017) 0.76
WAF1, a potential mediator of p53 tumor suppression. Cell (1993) 38.72
A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods (1991) 16.64
Cellular and molecular regulation of muscle regeneration. Physiol Rev (2004) 10.72
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature (1996) 7.04
MKK3- and MKK6-regulated gene expression is mediated by the p38 mitogen-activated protein kinase signal transduction pathway. Mol Cell Biol (1996) 6.91
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature (2000) 6.70
G1 cell-cycle control and cancer. Nature (2004) 5.72
Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem (1992) 5.60
Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science (1998) 4.92
Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol (1996) 3.71
The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta (2000) 3.33
Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev (1996) 3.26
Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol (2003) 3.25
Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem (1999) 3.12
p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J Biol Chem (1999) 3.09
Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J (1997) 2.97
p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Mol Cell Biol (2000) 2.96
Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem (2000) 2.78
Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene (2001) 2.71
Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci U S A (1995) 2.70
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J Immunol (2006) 2.57
Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev (2006) 2.55
Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol (1994) 2.44
Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev (1997) 2.40
p38-dependent phosphorylation of the mRNA decay-promoting factor KSRP controls the stability of select myogenic transcripts. Mol Cell (2005) 2.38
Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol (2005) 2.23
Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38alpha in abrogating myoblast proliferation. EMBO J (2007) 2.21
Induction of terminal differentiation by constitutive activation of p38 MAP kinase in human rhabdomyosarcoma cells. Genes Dev (2000) 2.21
Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science (1997) 2.18
Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science (1993) 1.99
Activated MEK1 binds the nuclear MyoD transcriptional complex to repress transactivation. Mol Cell (2001) 1.98
Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. FASEB J (2001) 1.88
Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol Cell Biol (2000) 1.88
IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell (2003) 1.86
Muscle differentiation: more complexity to the network of myogenic regulators. Curr Opin Genet Dev (1998) 1.68
Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res (2002) 1.63
Close encounters: regulation of vertebrate skeletal myogenesis by cell-cell contact. J Cell Sci (2005) 1.60
Cdc42Hs, but not Rac1, inhibits serum-stimulated cell cycle progression at G1/S through a mechanism requiring p38/RK. J Biol Chem (1997) 1.48
Netrins and neogenin promote myotube formation. J Cell Biol (2004) 1.47
Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem (2002) 1.46
Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis (2004) 1.39
Critical activities of Rac1 and Cdc42Hs in skeletal myogenesis: antagonistic effects of JNK and p38 pathways. Mol Biol Cell (2000) 1.39
Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol (1993) 1.38
Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J Biol Chem (1995) 1.38
Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res (2002) 1.37
Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem (1987) 1.34
Characterization of the human cell line TE671. Carcinogenesis (1989) 1.34
Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism. J Biol Chem (2005) 1.33
The epigenetic network regulating muscle development and regeneration. J Cell Physiol (2006) 1.28
p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol (2000) 1.25
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol (2004) 1.24
Signaling pathways weigh in on decisions to make or break skeletal muscle. Curr Opin Clin Nutr Metab Care (2004) 1.21
PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J Cell Sci (2002) 1.20
Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT. Mol Cell Biol (2005) 1.19
Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region. Cancer Res (2000) 1.15
Selective usage of D-Type cyclins by Ewing's tumors and rhabdomyosarcomas. Cancer Res (2004) 1.12
Differential effects between amphoterin and advanced glycation end products on colon cancer cells. Int J Cancer (2003) 1.09
Effector CD4 T cells are biochemically distinct from the memory subset: evidence for long-term persistence of effectors in vivo. J Immunol (1999) 1.08
Inactivation of MyoD-mediated expression of p21 in tumor cell lines. Cell Growth Differ (1997) 1.06
S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol (2003) 1.03
Differential expression of RAGE in human pancreatic carcinoma cells. Hepatogastroenterology (2002) 0.98
Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci (2000) 0.95
Rho GTPases and cadherin-based cell adhesion in skeletal muscle development. J Muscle Res Cell Motil (2003) 0.95
HMGB1 expression and release by bone cells. J Cell Physiol (2006) 0.95
Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochem Biophys Res Commun (2002) 0.93
Participation of small GTPases Rac1 and Cdc42Hs in myoblast transformation. Oncogene (2002) 0.91
Overexpression of the immunoglobulin superfamily members CDO and BOC enhances differentiation of the human rhabdomyosarcoma cell line RD. Mol Carcinog (2003) 0.89
Occipito-temporal connections in the human brain. Brain (2003) 3.46
S100B's double life: intracellular regulator and extracellular signal. Biochim Biophys Acta (2008) 1.97
Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis. Am J Respir Crit Care Med (2013) 1.45
S100B/RAGE-dependent activation of microglia via NF-kappaB and AP-1 Co-regulation of COX-2 expression by S100B, IL-1beta and TNF-alpha. Neurobiol Aging (2008) 1.39
S100B binding to RAGE in microglia stimulates COX-2 expression. J Leukoc Biol (2006) 1.33
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding. Mol Cell Biol (2004) 1.24
S100B protein stimulates microglia migration via RAGE-dependent up-regulation of chemokine expression and release. J Biol Chem (2011) 1.22
Distinct signaling pathways for induction of type II NOS by IFNgamma and LPS in BV-2 microglial cells. Neurochem Int (2005) 1.14
RAGE in tissue homeostasis, repair and regeneration. Biochim Biophys Acta (2012) 1.10
Causes of elevated serum levels of S100B protein in athletes. Eur J Appl Physiol (2012) 1.08
The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog (2011) 1.05
S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner. Mol Cell Biol (2003) 1.03
S100B Protein Regulates Astrocyte Shape and Migration via Interaction with Src Kinase: IMPLICATIONS FOR ASTROCYTE DEVELOPMENT, ACTIVATION, AND TUMOR GROWTH. J Biol Chem (2009) 1.01
Glucocorticoid-induced leucine zipper (GILZ) and long GILZ inhibit myogenic differentiation and mediate anti-myogenic effects of glucocorticoids. J Biol Chem (2010) 1.00
S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Cardiovasc Psychiatry Neurol (2010) 0.99
Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. Am J Physiol Cell Physiol (2009) 0.94
S100B stimulates myoblast proliferation and inhibits myoblast differentiation by independently stimulating ERK1/2 and inhibiting p38 MAPK. J Cell Physiol (2006) 0.93
S100B-stimulated NO production by BV-2 microglia is independent of RAGE transducing activity but dependent on RAGE extracellular domain. Biochim Biophys Acta (2004) 0.93
S100B protein in tissue development, repair and regeneration. World J Biol Chem (2013) 0.92
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients. PLoS One (2011) 0.91
S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner. J Cell Sci (2011) 0.90
S100B increases proliferation in PC12 neuronal cells and reduces their responsiveness to nerve growth factor via Akt activation. J Biol Chem (2004) 0.90
HMGB1-RAGE regulates muscle satellite cell homeostasis through p38-MAPK- and myogenin-dependent repression of Pax7 transcription. J Cell Sci (2012) 0.90
Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage. PLoS One (2010) 0.89
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA. Nat Commun (2013) 0.88
Human muscle satellite cells show age-related differential expression of S100B protein and RAGE. Age (Dordr) (2010) 0.87
S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration. PLoS One (2012) 0.87
S100b counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia. J Neurosci Res (2005) 0.86
S100A1 codistributes with synapsin I in discrete brain areas and inhibits the F-actin-bundling activity of synapsin I. J Neurochem (2004) 0.86
S100 calcium binding proteins and ion channels. Front Pharmacol (2012) 0.86
S100B protein in myoblasts modulates myogenic differentiation via NF-kappaB-dependent inhibition of MyoD expression. J Cell Physiol (2010) 0.85
S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J Cell Physiol (2004) 0.84
S100B-mediated inhibition of the phosphorylation of GFAP is prevented by TRTK-12. Neurochem Res (2004) 0.82
S100B secretion in acute brain slices: modulation by extracellular levels of Ca(2+) and K (+). Neurochem Res (2009) 0.82
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81
Chin stimulation: a trigger point for provoking acute hiccups. Respiration (2004) 0.81
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. J Biol Chem (2004) 0.80
Muscular dystrophies share pathogenetic mechanisms with muscle sarcomas. Trends Mol Med (2013) 0.79
Subcellular localization of S100A11 (S100C) in LLC-PK1 renal cells: Calcium- and protein kinase c-dependent association of S100A11 with S100B and vimentin intermediate filaments. Microsc Res Tech (2003) 0.79
Involvement of the S100B in cAMP-induced cytoskeleton remodeling in astrocytes: a study using TRTK-12 in digitonin-permeabilized cells. Cell Mol Neurobiol (2004) 0.78
Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity. Mol Cell Biochem (2002) 0.78
S100B in myoblasts regulates the transition from activation to quiescence and from quiescence to activation and reduces apoptosis. Biochim Biophys Acta (2010) 0.77
RAGE signaling deficiency in rhabdomyosarcoma cells causes upregulation of PAX7 and uncontrolled proliferation. J Cell Sci (2014) 0.76
Localisation of annexins in the retina of the rainbow trout-light and electron microscopical investigations. Brain Res (2005) 0.76
Subcellular localization of S100A11 (S100C, calgizzarin) in developing and adult avian skeletal muscles. Biochim Biophys Acta (2002) 0.76
The many faces of S100B protein: when an extracellular factor inactivates its own receptor and activates another one. Ital J Anat Embryol (2010) 0.76
NGF induces the expression of group IIA secretory phospholipase A2 in PC12 cells: the newly synthesized enzyme is addressed to growing neurites. Mol Neurobiol (2014) 0.75